|
TSC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.214200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.801600E-02 |
| Normal-vs-Stage2 |
8.787200E-01 |
| Normal-vs-Stage3 |
1.958960E-03 |
| Normal-vs-Stage4 |
4.081200E-01 |
| Stage1-vs-Stage2 |
2.812600E-01 |
| Stage1-vs-Stage3 |
1.249970E-01 |
| Stage1-vs-Stage4 |
8.627600E-01 |
| Stage2-vs-Stage3 |
4.368300E-02 |
| Stage2-vs-Stage4 |
4.835600E-01 |
| Stage3-vs-Stage4 |
5.656600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.956000E-02 |
| Normal-vs-AfricanAmerican |
4.360000E-01 |
| Normal-vs-Asian |
4.983100E-03 |
| Caucasian-vs-AfricanAmerican |
5.417600E-01 |
| Caucasian-vs-Asian |
1.499210E-01 |
| AfricanAmerican-vs-Asian |
1.739800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.098300E-02 |
| Normal-vs-Female |
2.777800E-01 |
| Male-vs-Female |
7.072600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.813200E-01 |
| Normal-vs-Extreme_Weight |
4.522900E-03 |
| Normal-vs-Obese |
3.969600E-01 |
| Normal-vs-Extreme_Obese |
8.134800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.585430E-01 |
| Normal_Weight-vs-Obese |
8.505400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.905600E-01 |
| Extreme_Weight-vs-Obese |
4.008300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.168600E-01 |
| Obese-vs-Extreme_Obese |
4.855400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.493000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.439600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.209550E-02 |
| Normal-vs-Age(81-100Yrs) |
1.397020E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.837000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.003400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.434810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.123800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.061000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.801500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.268000E-01 |
| Normal-VS-Type2 PRCC |
2.177300E-03 |
| Normal-VS-KIRP CIMP |
6.867200E-01 |
| Normal-VS-Unclassified PRCC |
3.116400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.904500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.515800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.319800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.796400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.959240E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.395200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.935400E-03 |
| Normal-vs-N1 |
2.907000E-01 |
| Normal-vs-N2 |
3.045800E-02 |
| N0-vs-N1 |
4.680200E-01 |
| N0-vs-N2 |
4.759800E-01 |
| N1-vs-N2 |
4.573400E-01 |
|
|
